Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus
Volume: 70, Issue: 2, Pages: 110 - 118
Published: Nov 1, 2005
Abstract
Simvastatin, a widely used 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitor, effectively reduced cardiac death and ischemic events in patients with coronary heart disease (CHD) and diabetes mellitus (DM). The mechanism of cardiovascular benefits of statins in DM remains unclear. We examined how simvastatin influences the levels of several in vivo markers for coagulation and fibrinolysis in 26 Type 2 DM patients. The diabetic patients...
Paper Details
Title
Impact of simvastatin on hemostatic and fibrinolytic regulators in Type 2 diabetes mellitus
Published Date
Nov 1, 2005
Volume
70
Issue
2
Pages
110 - 118
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History